THE NICKLES GROUP, LLC for GILEAD SCIENCES, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Monitored the implementation of P.L. 117-2, the American Rescue Plan and issues regarding COVID relief.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Budget/Appropriations BUD
Monitored S.Con.Res.14, FY 2022 Budget Resolution.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Government Issues GOV
Monitored issues related to the reimbursement of CAR-T cell therapy. H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 5376, the Build Back Better Act, and H.R. 19, the Lower Costs, More Cures Act, as they relate to drug pricing. Monitored H.R. 3684, The Infrastructure Investment and Jobs Act, as it relates to sequestration and drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER New | U.S. Senate Committee on Finance (Senators Crapo, Grassley, and Hatch)-Deputy Health Policy Director; Health Policy Dir.; Senior Policy Advsr; Policy Advisor. U.S. House of Representatives Committee on Ways and Means (Reps. Camp and Ryan) Prof. Staff |
Medicare/Medicaid MMM
Monitored issues related to the reimbursement of CAR-T cell therapy. Monitored H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 5376, the Build Back Better Act, and H.R. 19/S. 2164, the Lower Costs, More Cures Act, as they relate to drug pricing. Monitored H.R. 3684, The Infrastructure Investment and Jobs Act, as it relates to sequestration and drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.